Keywords: لیگاند RANK; BMAT; bone marrow adipose tissue; BMA; bone marrow adipocyte; WAT; white adipose tissue; cBMAT; constitutive BMAT; rBMAT; regulated BMAT; RANK ligand; receptor activator for NF-κB ligand; PPARγ; peroxisome proliferator-activated receptor gamma; BMAT; Si
مقالات ISI لیگاند RANK (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لیگاند RANK; RANK; receptor activator of nuclear factor kappa-B; HSA; hip structural analysis; BMD; bone mineral density; FREEDOM; Fracture Reduction Evaluation of Denosumab in Osteoporosis every 6Â Months; DIRECT; Denosumab fracture Intervention Randomized placebo Co
Keywords: لیگاند RANK; Denosumab; RANK ligand; Osteoporosis; Fracture; Drug safety;
Keywords: لیگاند RANK; Euterpe oleracea Mart.; Inflammation; Osteoclast; Cytokine; RANK ligand; Polyphenols
Keywords: لیگاند RANK; Oral cancer; Osteoprotegerin; Receptor activator of nuclear factor-kappa B; RANK ligand; Prognosis; Neoadjuvant therapy;
Keywords: لیگاند RANK; g; gravitational acceleration; RANK; receptor activator of nuclear factor kappa-B; RANKL; RANK ligand; OPG; osteoprotegerin; Dlx5; distal-less homeobox protein 5; ALP; alkaline phosphatase; NFATC1; nuclear factor of activated T cells, cytoplasmic 1; DCSTA
Keywords: لیگاند RANK; PDL; periodontal ligament; HIF-1α; hypoxia-inducible factor-1α; VEGF; vascular endothelial growth factor; BSP; bone sialoprotein; OCN; osteocalcin; DSP; dentin sialoprotein; OPN; osteopontin; OPG; Osteoprotegerin; RANK; receptor activator of nuclear fac
Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation
Keywords: لیگاند RANK; Macrophage; Osteoclast; RANK; RANKL; NFATc1; Necrostatin-7; RANK; receptor activator of nuclear factor-kappa B; RANKL; RANK ligand; M-CSF; macrophage colony-stimulating factor; MAPK; mitogen-activated protein kinase; ERK; extracellular signal-regulated ki
PTH (1-34) affects bone turnover governed by osteocytes exposed to fluoride
Keywords: لیگاند RANK; Fluorides; Parathyroid hormone; Osteocytes; Sclerostin protein; RANK ligand;
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma
Keywords: لیگاند RANK; Lung adenocarcinoma; RANK ligand; Genetically engineered mouse models; Preclinical trial;
aPDT for periodontitis treatment in ovariectomized rats under systemic nicotine
Keywords: لیگاند RANK; Nicotine; Ovariectomy; Periodontitis; Photochemotherapy; RANK ligand;
FGF2 and FAM201A affect the development of osteonecrosis of the femoral head after femoral neck fracture
Keywords: لیگاند RANK; ONFH; osteonecrosis of the femoral head; FNF; femoral neck fracture; DEGs; differentially expressed genes; PPI; protein-protein interaction; VEGF; vascular endothelial growth factor; HIF-1α; hypoxia-inducible factor-1 alpha; OPG; osteoprotegerin; RANK; r
ReviewGiant cell tumour of bone in the denosumab era
Keywords: لیگاند RANK; Denosumab; RANK ligand; Giant cell tumour of bone;
Original ArticlePharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis
Keywords: لیگاند RANK; NFκB; β-Catenin; Breast cancer; Osteolysis; Bone; PTN; Parthenolide; NFκB; nuclear factor kappa-B; RANK; receptor activator of NFκB; RANKL; RANK ligand; TNFα; tumour necrosis factor alpha; IL1β; interleukin 1 beta; CD40L; Cluster of differentiation
Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: An in vitro study
Keywords: لیگاند RANK; LIPUS, low-intensity pulsed ultrasound; RANKL, recombinant murine soluble receptor activator of NF kappa B ligand; OC, osteoclast; ICC, intra-class correlation coefficientOrthodontics; Cell biology; In vitro techniques; RANK ligand; Bone resorption; Tooth
Immune-Inflammatory Cell Profile and Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin Expression in Persistent Apical Periodontitis after Root Canal Retreatment Failure
Keywords: لیگاند RANK; Apical periodontitis; bone resorption; immunological cells; osteoprotegerin; RANK ligand
Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism
Keywords: لیگاند RANK; 1,25D; 1,25-dihydroxyvitamin D; Agg; aggregan; ALP; alkaline phosphatase; BRU; bone remodeling unit; CaSR; extracellular calcium-sensing receptor; [Ca2+]e; extracellular calcium concentration; Col(I); type I collagen; α1(I); alpha 1 subunit of the type I
Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts
Keywords: لیگاند RANK; Osteoprotegerin; periradicular cyst; RANK ligand; receptor activator of nuclear factor-κB
Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
Keywords: لیگاند RANK; RANK; activator of NF-κB; RANKL; RANK ligand; OPG; osteoprotegerin; TRANCE; TNF-related activation-induced cytokine; TNF; tumor necrosis factor; IL; interleukin; DC; dendritic cell; DTCs; disseminated tumor cells; SREs; skeletal-related events; ZOL; zole
Original Full Length ArticleSTAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells
Keywords: لیگاند RANK; TRAIL; RANK ligand; STAT-6; Stromal/preosteoblasts;
Receptor activating NF-κB ligand (RANKL) is a constitutive intracellular protein in resting human basophils and is strongly induced on their surface by interleukin 3
Keywords: لیگاند RANK; BDCA; blood dendritic cell antigen; DC; dendritic cells; HPRT; hypoxanthine-guanine phosphoribosyltransferase; LN; lymph node; MoDC; monocyte-derived DC; OPG; osteoprotegerin; PB; peripheral blood; pDC; plasmacytoid DC; RANK; receptor activating NF-κB;
Molecular mechanisms for bone resorption by gingipains: Degradation of osteoprotegerin by lysine-specific gingipain is a key factor for enhanced osteoclastogenesis
Keywords: لیگاند RANK; Rgp; arginine-specific gingipain; Kgp; lysine-specific gingipain; RANK; receptor activator of nuclear factor κB; RANKL; RANK ligand; OPG; osteoprotegerin; TLR; Toll-like receptor; LPS; lipopolysaccharides; PGE2; prostaglandin E2; IL; interleukin; TNF; tu
Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture
Keywords: لیگاند RANK; Fabp; fatty acid-binding protein; Hes; Hairy Enhancer of Split; Hey; Hes-related with YRPW motif; HeyL; Hey-like; kb; kilobase; μCT; microcomputed tomography; Osx; osterix; Rank; receptor activator of NF-kappa-B; Rankl; Rank ligand; SEM; standard error o
Case ReportSustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab
Keywords: لیگاند RANK; Denosumab; Giant cell tumor; RANK ligand; Primary bone tumors; Upper cervical spine; En bloc resection; Osteogenesis; Osteolysis;
Effects of Cachaça, a typical Brazilian alcoholic beverage, on alveolar bone loss and density: A study in peripubertal rats
Keywords: لیگاند RANK; Ethanol; Alveolar bone loss; Ligature; Tartrate-resistant acid phosphatase; RANK ligand; Osteoprotegerin;
Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial
Keywords: لیگاند RANK; denosumab; osteoclasts; prostatic neoplasms; RANK ligand; urinary N-telopeptide of type I collagen, humanAE, adverse event; BCE, bone collagen equivalents; BP, bisphosphonates; Cr, creatinine; ECOG, Eastern Cooperative Oncology Group; IV, intravenous; Q4W
Modeling hepatic osteodystrophy in Abcb4 deficient mice
Keywords: لیگاند RANK; Chronic cholangitis; Liver fibrosis; Osteoporosis; RANK ligand; Vitamin D
The extracellular calcium-sensing receptor, CaSR, in fetal development
Keywords: لیگاند RANK; calcium-sensing receptor; fetal hypercalcemia; skeletal development; fetal lung development; growth plate cartilage; osteoblasts; RANK ligand
Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data
Keywords: لیگاند RANK; denosumab; osteoporosis; RANK; RANK ligand; RANKL
Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo
Keywords: لیگاند RANK; Doxycycline; Osteoclast; RANK ligand; MMP-9; MAPKs; NFATc1
Denosumab and bisphosphonates: Different mechanisms of action and effects
Keywords: لیگاند RANK; Bisphosphonates; Denosumab; Osteoclast; Osteoporosis; RANK ligand;
Rheumatoid arthritis and periodontal disease
Keywords: لیگاند RANK; Rheumatoid arthritis; Periodontitis; Periodontium; Porphyromonas gingivalis; Citrullination; RANK Ligand
Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy
Keywords: لیگاند RANK; Osteoprotegerin; RANK ligand; Diabetes; Nephropathy; HMG-CoA reductase inhibitors; Lovastatin
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression
Keywords: لیگاند RANK; Rotenone; Osteoclasts; RANK ligand; Osteoporosis; Lipopolysaccharides;
Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model
Keywords: لیگاند RANK; G-CSF; granulocyte colony-stimulating factor; GM-CSF; granulocyte-macrophage colony-stimulating factor; HGF; hepatocyte growth factor; IL; interleukin; MCP-1; monocyte chemotactic protein 1; MMP; matrix metalloproteinase; OPG; osteoprotegrin; OPN; osteopo
RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer
Keywords: لیگاند RANK; Bone; Bone metastases; Breast cancer; Denosumab; Prostate cancer; RANK; RANK Ligand
The affinity of human RANK binding to its ligand RANKL
Keywords: لیگاند RANK; Receptor activator of nuclear factor-kappa B; RANK ligand; RANK–RANKL interaction; Surface plasmon resonance; Affinity of RANK–RANKL
RANK Ligand Inhibition: A Novel Strategy for the Treatment of Bone Metastases
Keywords: لیگاند RANK; Bone metastases; Denosumab; RANK Ligand; RANK Ligand inhibitor; N-telopeptide; Bone markers; Cancer-induced bone disease
RANK Ligand: A Key Role in Cancer-Induced Bone Destruction?
Keywords: لیگاند RANK; Bone; Bone metastases; Cancer; Cancer treatment-induced bone loss; Denosumab; OPG; Osteoprotegerin; RANK; RANK Ligand
Advances in the Therapy of Prostate Cancer–Induced Bone Disease: Current Insights and Future Perspectives on the RANK/RANKL Pathways
Keywords: لیگاند RANK; Bone diseases; Bone formation; Bone metastases; Bone resorption; Osteoblasts; Osteoclasts; Prostate cancer; RANK ligand
Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Keywords: لیگاند RANK; RANK ligand; denosumab; clinical trial; bone resorption; prostatic neoplasmsADT, androgen deprivation therapy; BMD, bone mineral density; BMI, body mass index; GnRH, gonadotropin-releasing hormone; RANKL, receptor activator of nuclear factor κB ligand; sC
Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial
Keywords: لیگاند RANK; denosumab; osteoclasts; prostatic neoplasms; RANK ligand; urinary N-telopeptide of type I collagen; humanAE, adverse event; BCE, bone collagen equivalents; BP, bisphosphonates; Cr, creatinine; ECOG, Eastern Cooperative Oncology Group; IV, intravenous; Q4W
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
Keywords: لیگاند RANK; Bone mineral density; denosumab; monoclonal antibody; osteoporosis; RANK ligand;
Genetics of Rheumatoid Arthritis
Keywords: لیگاند RANK; AICAR-T; aminoimidazole carboxamide ribonucleotide transformylase; CRH; corticotropin-releasing hormone; DMARD; disease-modifying antirheumatic drug; IL; interleukin; MHC; major histocompatibility complex; MTHFR; methylenetetrahydrofolate reductase; RA; r
Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells
Keywords: لیگاند RANK; Bone loss; c-Fos; Calcitonin receptor; RANK ligand; Monocyte; Osteoblast
Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells
Keywords: لیگاند RANK; Mechanotransduction; Substrate deformation; Osteoprotegerin; RANK ligand; Bone
The osteoblast-heparan sulfate axis: Control of the bone cell lineage
Keywords: لیگاند RANK; HS; heparan sulfate; HSPG; heparan sulfate proteoglycans; ECM; extracellular matrix; Wnt; wingless-int growth factor; FGF; fibroblast growth factor; FGFR; FGF receptor; BMP; bone morphogenic protein; BMPR; BMP receptor; TGF-β; transforming growth factor-
RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells
Keywords: لیگاند RANK; Osteoclast; RANK ligand; Interferon-γ; Cathepsin K; Cathepsin S; Cathepsin L;
The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone
Keywords: لیگاند RANK; Receptor activator of NF:κB (RANK); RANK ligand; RANK:Fc protein; Osteoclastogenesis; Bone metastasis;
Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins
Keywords: لیگاند RANK; Bone mineral density; RANK ligand; Osteoprotegerin; Genetics; Twins;